Special Issues
Table of Content

From Reproductive Biology to Cancer: Molecular Links and Therapeutic Innovations

Submission Deadline: 30 January 2027 View: 25 Submit to Special Issue

Guest Editor(s)

Prof. Giuseppe Gullo

Email: gullogiuseppe@libero.it

Affiliation: Department of Obstetrics and Gynecology, AOOR Villa Sofia-Cervello, University of Palermo, Palermo, Italy

Homepage:

Research Interests: ovarian cancer, molecular mechanisms, reproductive tract malignancies, gynecologic cancer biology, reproductive biology

image2 (3).jpeg


Prof. Vito Chiantera

Email: vito.chiantera@unicampania.it

Affiliation: 1. Obstetrics and Gynecology Unit, Department of Woman, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", Naples, Italy

2. Unit of Gynecologic Oncology, National Cancer Institute - IRCCS - Fondazione "G. Pascale", Naples, Italy

Homepage:

Research Interests: ovarian cancer, gynecologic malignancies, endometrial cancer

image3.jpeg


Summary

This Special Issue focuses on the molecular connections between normal reproductive processes and the development of reproductive tract cancers. Reproductive biology shares key pathways with oncogenesis, such as hormone signaling, DNA repair, inflammation, and epithelial-mesenchymal transition. We invite original research and review articles that explore these links and translate them into therapeutic innovations. Topics of interest include:
· Hormonal drivers of ovarian, endometrial, and breast cancers
· DNA repair defects (e.g., BRCA, HRD) and PARP inhibitor strategies
· Endometriosis-associated ovarian carcinogenesis
· Immunotherapy and targeted agents in gynecologic malignancies
· Cancer stem cells and drug resistance mechanisms
· Predictive biomarkers for precision oncology


This Special Issue welcomes mechanistic studies, drug development reports, and translational research that bridge reproductive biology and cancer therapy. Both original articles and systematic reviews are encouraged.


Keywords

reproductive cancers, gynecologic oncology, hormone signaling, DNA repair, PARP inhibitors, immunotherapy, drug resistance, precision medicine

Share Link